Plasma abnormal prothrombin (Des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
1966 • 4,504 citations
Hepatogastroenterology
2011 • 2,829 citations
Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
1984 • 576 citations
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report
1983 • 332 citations
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis
1986 • 317 citations
Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients.
1984 • 268 citations
Diagnosis and Clinical Features of Small Hepatocellular Carcinoma With Emphasis on the Utility of Real-Time Ultrasonography
1984 • 235 citations
Primary liver cancer
1989 • 187 citations
The Function and Metabolism of Vitamin K
1984 • 164 citations
Detection of Vitamin K Deficiency by Use of an Enzyme-Linked Immunosorbent Assay for Circulating Abnormal Prothrombin
1985 • 117 citations
EFFECT OF VITAMIN K ADMINISTRATION ON ACARBOXY PROTHROMBIN (PIVKA-II) LEVELS IN NEWBORNS
1985 • 101 citations
Primary liver cancer
1986 • 75 citations
A New Method to Assay Des-γ-carboxyprothrombin
1986 • 71 citations
Serum tumor markers in patients with hepatocellular carcinoma: Diagnosis of α-fetoprotein -low or -negative patients
1985 • 18 citations
Acarboxy Prothrombin (PIVKA-II) as a Marker of Hepatoblastoma in Infants
1987 • 11 citations
Studies on contents of phylloquinone and menaquinones family in native serum and feces from human adults and newborn infants.
1985 • 3 citations
Cited By (0)
No citing papers found in database